Duquesne University School of Pharmacy
Sewickley, Pennsylvania
Karen M. Fancher, PharmD, BCOP, is an Associate Professor of Pharmacy Practice at Duquesne University School of Pharmacy in Pittsburgh, Pennsylvania. She is a graduate of Duquesne University School of Pharmacy and completed a Pharmacy Practice Residency at Thomas Jefferson University Hospital in Philadelphia, followed by a Specialty Residency in Oncology Pharmacy Practice at the H. Lee Moffitt Cancer Center and Research Institute in Tampa. She then spent almost 10 years as a Clinical Pharmacist in the Blood and Marrow Transplant Division at the H. Lee Moffitt Cancer Center before returning to Pittsburgh to work with the West Penn Allegheny Oncology Network. Dr. Fancher's current practice site is the University of Pittsburgh Medical Center at Passavant Hospital. She presently serves on the faculty for the Board Certification in Oncology Pharmacy (BCOP) Review & Recertification course, as well as on various committees of the Hematology Oncology Pharmacy Association (HOPA) and the Advanced Topics for Oncology Pharmacy Professionals (ATOPP) Summit. She has repeatedly been voted as the “Teacher of the Year” by students in the School of Pharmacy and has also been nominated for ASHP's Preceptor of the Year Award. Dr. Fancher's research interests include chronic leukemias and ethics in oncology.
Acerta/AstraZeneca (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board; BTG (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board; G1 Therapeutics (Individual(s) Involved: Self; Clinical Condition: Oncology): Speaker's Bureau; Merck (Individual(s) Involved: Self; Clinical Condition: Oncology): Advisory Board
Thursday, April 28, 2022
11:10 AM – 11:45 AM
Thursday, April 28, 2022
11:45 AM – 11:55 AM
Friday, August 12, 2022
11:10 AM – 11:45 AM
Friday, August 12, 2022
11:45 AM – 11:55 AM
Friday, August 12, 2022
12:10 PM – 12:40 PM
Friday, November 18, 2022
11:10 AM – 11:45 AM
Friday, November 18, 2022
11:45 AM – 11:55 AM
Exclusive Content
Exclusive Content
Exclusive Content